期刊文献+

10种中成药体外抗流感病毒活性研究 被引量:12

In vitro anti-influenza virus activity of 10 traditional Chinese medicines
原文传递
导出
摘要 流感是一种高发病率和高死亡率的上呼吸道传染病,我国是流感高发区。国际上预防与治疗流感的主要措施是疫苗接种和抗病毒化学药物治疗。除此之外我国临床上还利用传统中药进行抗流感病毒治疗。本研究采用细胞病变(CPE)法,对10种中成药进行体外抗流感病毒活性检测。厂家H生产的清热解毒口服液体外对A/广东罗湖/219/2006(H1N1)具有较强的抑制活性;银黄口服液对A/汉防/359/95和A/粤防/243/72,厂家G生产的清开灵口服液对A/济防/15/90,厂家H生产的清热解毒口服液对A/济防/15/90、A/粤防/243/72和B/深圳/155/2005具有较强的抑制活性。 Influenza virus is a virus causing upper respiratory tract infection disease with high morbidity and mortality. China is considered as an area with high rate of influenza morbidity. Prevention and treatment of influenza currently rely on vaccines and antiviral agents in the world. In addition, traditional Chinese medicines also have been used in clinical for influenza therapy. In vitro anti-influenza virus activities of 10 traditional Chinese medicines were studied by cytopathic effect (CPE). Qingre Jiedu oral liquid (factory H) had strong antiviral activity against influenza virus A/Guangdong Luohu/219/2006 (H1N1); Yinhuang oral liquid had strong antiviral activity against influenza virus A/Hanfang/359/95 and A/Yuefang/243/72 (H3N2). Qingkailing oral liquid (factory G) had strong antiviral activity against influenza virus A/Jifang/15/90 (H3N2). Qingre Jiedu oral liquid (factory H) had strong antiviral activity against influenza virus A/Jifang/15/90, A/Yuefang/243/72 (H3N2) and virus B.
出处 《药学学报》 CAS CSCD 北大核心 2010年第3期395-398,共4页 Acta Pharmaceutica Sinica
基金 科技部甲型H1N1流感联防联控应急科研项目
关键词 中成药 抗流感病毒 体外 细胞病变法 traditional Chinese medicine anti-influenza virus in vitro cytopathic effect
  • 相关文献

参考文献10

  • 1EIsieh YC, Wu TZ, Liu DP, et al. Influenza pandemics: past,present and future [J]. J Formosan Med Assoc, 2006, 105: 1-6.
  • 2Schnitzler SU, Schnitzler E An update on swine-origin influenza virus A/H1NI: a review [J]. Virus Genes, 2009, 39: 279-292.
  • 3Centers for Disease Control and Prevention (CDC). Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009 [J]. MMWR Morb Mortal Wkly Rep, 2009, 58: 433-435.
  • 4LiY.The clinical application and advantage of traditional Chinese medicine treatment against acute respiratory infection .时珍国医国药,2008,19:1014-1015.
  • 5ZhangQW.The newest advance of antiviral traditional Chinese medicines .中成药,2005,27:116-119.
  • 6Monto AS. Antivirals and influenza frequency of resistance [J]. Pediatr Infect Dis J, 27: s110-112.
  • 7Maltezou HC, Tsiodras S. Antiviral agents for influenza: molecular targets, concerns of resistance, and new treatment options [J]. Curr Drug Targets, 2009, 10: 1041-1048.
  • 8Chen HL. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China [J]. Emerg Infect Dis, 2009, 15: 1970-1972.
  • 9CaoY.Advance of Chinese medicine anti-influenza virus experimental study .浙江临床医学,2008,10:1604-1605.
  • 10YangDF.Advance of Chinese medicine anti-influenza virus mechanism study .中国中医急症,2007,12:988-989,994.

同被引文献126

引证文献12

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部